Recoverable hearing loss with amphetamines and other drugs

被引:13
|
作者
Iqbal, N [1 ]
机构
[1] AL Amal Hosp, Jeddah, Saudi Arabia
关键词
amphetamine; depression; drugs; hearing; psychosis; suicidality;
D O I
10.1080/02791072.2004.10399740
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Prolonged and sustained consumption of alcohol, heroin and volatiles had been reported to impair hearing. Amphetamine related hearing loss is clinically different from the hearing loss seen with other agents. It seems that illicit drug use could result in two clinically different types of hearing losses. In May and June of 2001, 183 men aged 18 and above who met DSM-IV criteria for substance dependence were studied in a hospital in Sandia Arabia. The purpose of the study was to ascertain the prevalence of amphetamine-related recoverable hearing loss, establish whether similar hearing loss also occurred with other drugs of abuse and determine if drug-related psychosis was more prevalent in those amphetamine users who developed this type of hearing loss. Recoverable type of hearing loss was not just seen in amphetamine users but also occurred with cannabis, heroin, alcohol, dextromethorphan and glue use. Drug-induced psychosis was three and a half times more common in those amphetamine users who developed a hearing loss. Major depression and suicidality was also more common in these individuals. This association of major depression and subsequent development of hearing loss was also found in those using other type of drugs. It was concluded that a history of major depression was a good predictor of later development of both drug-induced psychosis and hearing loss in amphetamine users, and hypoperfusion was proposed as the possible explanation.
引用
收藏
页码:285 / 288
页数:4
相关论文
共 50 条
  • [1] DEPENDENCE ON AMPHETAMINES AND OTHER STIMULANT DRUGS
    不详
    [J]. JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1966, 197 (12): : 1023 - &
  • [2] Additional Information on Drugs and Hearing Loss
    Holt, Glen E.
    [J]. PUBLIC LIBRARY QUARTERLY, 2015, 34 (01) : 97 - 98
  • [3] Early investigational drugs for hearing loss
    Mukherjea, Debashree
    Ghosh, Sumana
    Bhatta, Puspanjali
    Sheth, Sandeep
    Tupal, Srinivasan
    Borse, Vikrant
    Brozoski, Thomas
    Sheehan, Kelly E.
    Rybak, Leonard P.
    Ramkumar, Vickram
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2015, 24 (02) : 201 - 217
  • [4] Hearing loss, exercise, ... and other stories
    不详
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2021, 373
  • [5] Hearing loss without other characteristics
    Brudermanns, Britta
    [J]. LARYNGO-RHINO-OTOLOGIE, 2009, 88 (07) : 440 - 441
  • [6] Hearing loss in singers and other musicians
    Sataloff, RT
    [J]. MEDICAL PROBLEMS OF PERFORMING ARTISTS, 1997, 12 (02) : 51 - 56
  • [7] ROCHE PACT PURSUES HEARING LOSS DRUGS
    不详
    [J]. CHEMICAL & ENGINEERING NEWS, 2012, 90 (42) : 19 - 19
  • [8] CHLORINATED AMPHETAMINES - DRUGS OR TOXINS
    LOVENBERG, W
    WALKER, M
    BAUMGARTEN, HG
    [J]. AGENTS AND ACTIONS, 1975, 5 (05): : 501 - 501
  • [9] Intoxication with amphetamines and designer drugs
    Felgenhauer, N
    Zilker, T
    [J]. INTERNIST, 1999, 40 (06): : 617 - +
  • [10] Experimental drugs for the prevention or treatment of sensorineural hearing loss
    Kempfle, Judith S.
    Jung, David H.
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2023, 32 (07) : 643 - 654